RE: ASK1, a new target in treating cardiorenal syndrome (CRS).

Int J Cardiol

Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address:

Published: October 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2020.05.050DOI Listing

Publication Analysis

Top Keywords

ask1 target
4
target treating
4
treating cardiorenal
4
cardiorenal syndrome
4
syndrome crs
4
ask1
1
treating
1
cardiorenal
1
syndrome
1
crs
1

Similar Publications

Ginsenoside Rh2 promotes cell apoptosis in T-cell acute lymphocytic leukaemia by MAPK and PI3K/AKT signalling pathways.

Nat Prod Res

December 2024

State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Fermentation Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.

T-cell acute lymphoblastic leukaemia (T-ALL) is a common childhood malignant tumour, which has poor prognosis and high recurrence rate. Ginsenoside Rh2 (GRh2), a bioactive ingredient of has significant anti-tumour effect. In this study, we found that gene expressions of Jurkat cells were significantly changed in the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) signalling pathways after 35 µm GRh2 treatment, involving in JUN, PIEN, AKT3 and MAPK8IP2.

View Article and Find Full Text PDF

Introduction: This work aims to validate the ameliorative influence of metformin against endoplasmic reticulum stress (ERS)-prompted apoptosis caused by vanadium pentoxide (VO) or gamma-irradiation (γ-irradiation) in hepatic tissues of male rats.

Methods: There were six groups of rats: the control, metformin (100 mg/kg body weight, .), VO (12.

View Article and Find Full Text PDF

Background: An ideal anti-diabetic type-1 pharmacotherapy should combine abrogation of beta cell pyroptosis with enhancement of beta cell mass.

Objectives: The study investigated the potential synergism from combining the Bacillus Calmette-Guerin (BCG) vaccine with liraglutide (LIR) and probiotics in mitigating Streptozocin (STZ)-induced Type1diabetes mellitus in albino rats suppression of TXNIP/NLRP3 signaling. Induction of diabetes was performed by two I.

View Article and Find Full Text PDF

Ginsenoside compound K alleviates brain aging by inhibiting ferroptosis through modulation of the ASK1-MKK7-JNK signaling pathway.

Phytomedicine

December 2024

Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi'an 710127, China; Biotech. & Biomed. Research Institute, Northwest University, Xi'an 710127, China. Electronic address:

Background: Aging of the brain is a major contributor to the onset and progression of neurodegenerative diseases. Conventional treatments for these diseases are often limited by significant side effects and a lack of efficacy in halting disease progression. Ginsenoside compound K (CK), a bioactive secondary metabolite derived from ginseng, has shown promise because of its potent antioxidant properties.

View Article and Find Full Text PDF

AIP1 Regulates Ocular Angiogenesis Via NLRP12-ASC-Caspase-8 Inflammasome-Mediated Endothelial Pyroptosis.

Adv Sci (Weinh)

December 2024

Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Jinan University, Shenzhen, Guangdong, 518043, China.

Article Synopsis
  • Pathological ocular angiogenesis causes significant vision loss and blindness, and the study identifies AIP1 as a key anti-angiogenic factor in retinal vascular endothelial cells (VECs) in an oxygen-induced retinopathy model.
  • AIP1 inhibits pathological angiogenesis by preventing pyroptosis, an inflammatory cell death pathway, which is linked to the formation of the NLRP12-ASC-caspase-8 inflammasome that exacerbates retinal neovascularization.
  • The study highlights a new inflammatory mechanism in ocular angiogenesis and suggests targeting AIP1 or pyroptosis could lead to new treatments for vascular eye diseases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!